ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

Go back to ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.45 +0.60 (5.53%)
Previous Close $10.85    52 Week High $2.18 
Open $11.40    52 Week Low $0.30 
Day High $11.79    P/E N/A 
Day Low $11.38    EPS $-3.32 
Volume 239,368       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.45 +0.60 (5.53%)
Previous Close $10.85    52 Week High $2.18 
Open $11.40    52 Week Low $0.30 
Day High $11.79    P/E N/A 
Day Low $11.38    EPS $-3.32 
Volume 239,368